Clinical Trial

Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults

Study acronym: CRASH-4
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and dementia in older adults with symptomatic mild head injury
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-08-18; most recent amendment 2026-03-09.
Status change: Not Yet Recruiting → Recruiting 2021-05-11
Trial Details
NCT Number NCT04521881
Lead Sponsor London School of Hygiene and Tropical Medicine
Conditions Traumatic Brain Injury
Enrollment 5,000 participants
Start Date 2021-04-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-12